

02 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/vaderis-therapeutics-announces-the-new-england-journal-of-medicine-publishes-engasertib-proof-of-concept-and-long-term-extension-results-highlighting-the-therapys-potential-for-patients-with-hereditary-hemorrhagic-telangiectasia-302628280.html